1. Home
  2. IPW vs EDVA Comparison

IPW vs EDVA Comparison

Compare IPW & EDVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

BUY

Current Price

$0.40

Market Cap

1.1M

ML Signal

BUY

EDVA

Endovia Health Sciences Inc. Common Stock

N/A

Current Price

$0.14

Market Cap

1.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
IPW
EDVA
Founded
2018
N/A
Country
United States
United States
Employees
4
N/A
Industry
Catalog/Specialty Distribution
Beverages (Production/Distribution)
Sector
Consumer Discretionary
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
1.2M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
IPW
EDVA
Price
$0.40
$0.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
★ 1.8M
Earning Date
10-02-2026
11-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 32.30
EPS
N/A
★ N/A
Revenue
★ $19,956,938.00
$73,066.00
Revenue This Year
$596.00
$24,377.87
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.34
$0.13
52 Week High
$4,092,187,400.00
$0.33

Technical Indicators

Market Signals
Indicator
IPW
EDVA
Relative Strength Index (RSI) 24.74 23.13
Support Level N/A N/A
Resistance Level $1.57 $0.18
Average True Range (ATR) 0.16 0.01
MACD 34.28 0.00
Stochastic Oscillator 4.85 18.80

Price Performance

Historical Comparison
IPW
EDVA

About IPW iPower Inc.

iPower Inc is a technology-enabled commerce infrastructure company providing supply chain, logistics, fulfillment, warehousing and procurement solutions for e-commerce and distribution channels. Its product portfolio includes hydroponic products, gardening supplies, home goods and related accessories, with gardening and home products. Geographically, the company generates majority of its revenue from the United States, followed by Canada and other international markets.

About EDVA Endovia Health Sciences Inc. Common Stock

Endovia Health Sciences Inc is building a diversified cannabinoid health sciences platform through pharmaceutical innovation, strategic partnerships and disciplined execution. Endovia acquires, develops and commercializes differentiated cannabinoid health technologies across pharmaceutical, veterinary and consumer wellness markets. Endovia's product begins with CannEpil, a cannabinoid pharmaceutical asset, and extends into veterinary development and consumer wellness as the pipeline expands.

Share on Social Networks: